We are after a Senior Microscopist and Facility Manager. This is a key Life science appointment for us so please send across your networks 🙌 www.jobs.ac.uk/job/DQX551/s...
Posts by Lee Machado
Always happy to be back @unibirmingham.bsky.social . Today the fantastic Midlands Innovation Flow cytometry annual meeting! Looking forward to Chairing Session 3 with some fantastic academic and commercial speakers!
Happy Christmas from our lab. Some projects funded, others not; some papers out, some still need to be written, some PhDs completed and others just beginning. We take the highs with the lows, let's see what 2026 brings...🎄🎅🌲
"Due to a variety of circumstances...many science projects will never be finished, despite years of invested resources and effort. By carefully and strategically documenting scientific work achieved, components of unfinished projects can be salvaged and preserved to benefit future researchers." 🧪
Looking forward to popping over for a nose at some point! 😉
Academics! Delighted to announce that the new 3rd edition of Human Evolutionary Genetics is now available to book inspection copies. Available to buy January 9th. 1/5
www.routledge.com/Human-Evolut...
www.youtube.com/watch?v=f9Vo...
A fab inaugural from Prof Havovi Chichger. Sweet signals, bitter truths: taste sensing and cardiovascular disease youtube.com/live/f9VoIBqPP… via @YouTube
#News&Views
Epstein–Barr virus is associated with cancer and implicated in autoimmune diseases. Three studies reveal desmocollin 2 and R9AP as receptors for Epstein–Barr virus infection, highlighting new avenues for targeted therapies.
#MicroSky 🦠
www.nature.com/articles/s41...
Looking forward to using our new Seahorse across a bunch of projects for metabolic studies…just having to re-learn my undergraduate biochemistry though 😉
A unified model for Duchenne muscular dystrophy gene involvement in cancer: context-dependent tumour suppression and oncogenicity
🔦 buff.ly/lBnkwMP
🥼 @drleemachado.bsky.social
#CancerResearch #DuchenneMuscularDystrophy
Great to catch up with my fab friend Tim (from our undergraduate days) who was recently promoted to Prof. in Structural Biology at the University of Birmingham.
Quite amusing sitting on a train overhearing two international scientists converse about cholera toxins, phage, E.Coli, yeast two hybrids…must be terrifying if you’re a non-scientist passenger sat in earshot 😂
8/8 Key message:
🧬 DMD is not uniformly oncogenic or tumour suppressive.
🧩 Isoform Dp71ab may be central.
📈 Any therapeutic approach must consider tumour context.
febs.onlinelibrary.wiley.com/doi/10.1002/...
7/8 For me, this project reflects pivoting in research. Learning bioinformatics during COVID provided the tools to take this forward, and collaborating with @Weekademia, it has now matured into a published study and a new framework to functionally test.
6/8 Supporting evidence:
Aggressive cancers often downregulate/mutate DMD.
Less aggressive cancers retain intact DMD.
So, DMD’s role is context-dependent.
5/8 From this, we propose a dual model:
In aggressive cancers, DMD acts as a tumour suppressor.
In less aggressive cancers, DMD can play an oncogenic role.
4/8 Pathway analysis revealed two contrasting patterns:
High DMD protective → ECM integrity & adhesion preserved.
High DMD harmful → morphogenesis & cellular plasticity promoted.
3/8 Isoform analysis was crucial:
Dp71ab was the dominant transcript and mirrored survival patterns.
Dp40 also appeared consistently.
This suggests isoforms, not just total DMD drive the biology.
2/8 Using TCGA data (33 cancers), we found DMD expression significantly linked to survival in 9 cancers.
But the direction split:
High DMD = ⬆️ survival (breast, lung, pancreas, AML, uveal melanoma)
High DMD = ⬇️ survival (glioma, thymoma, kidney and rectal)
1/8 The Duchenne muscular dystrophy gene (DMD) is well known in muscle biology, but in cancer its role has been puzzling.
Some studies showed high DMD = better survival. Others showed the opposite.
We set out to explain why.
🚨 New in FEBS Open Bio!
During COVID, with labs disrupted, I undertook an MRes apprenticeship in bioinformatics. As a professor, I was suddenly a student again, learning coding to support my group.
Together with @Weekademia, we propose a unified model of DMD in cancer. 🧵👇
A formative experience for me working at Novartis for a year in the late 90s www.alexkesin.com/p/the-day-no... The Day Novartis Chose Discovery